The NLRP3 Mediates Masticatory Muscle Atrophy by Pyroptosis and Mitophagy

Q Li1, A Gao1, C Wu1

  • 1College & Hospital of Stomatology, Anhui Medical University, Key Laboratory of Oral Diseases Research of Anhui Province, Hefei, China.

PubMed

Insights

The Nod-like receptor protein 3 (NLRP3) inflammasome drives masticatory muscle atrophy by causing cell death and mitochondrial damage. Inhibiting NLRP3 protects against muscle loss and dysfunction.

Area of Science:

  • Biomedical Science
  • Molecular Biology
  • Muscle Physiology

Background:

  • Masticatory muscle atrophy impacts occlusal function, facial aesthetics, and quality of life.
  • The molecular underpinnings of masticatory muscle atrophy are not well understood.
  • The Nod-like receptor protein 3 (NLRP3) inflammasome is implicated in various myopathies, but its role in masticatory muscle atrophy is unclear.

Purpose of the Study:

  • To investigate the role and mechanisms of NLRP3 inflammasome activation in masticatory muscle atrophy.
  • To explore NLRP3 inflammasome's impact on myocyte pyroptosis, mitochondrial function, and mitophagy in muscle atrophy models.

Main Methods:

  • Utilized in vivo rat models with excessive orthodontic traction to induce masticatory muscle atrophy.
  • Conducted in vitro experiments on myotubes to assess NLRP3 inflammasome activation effects.
  • Employed molecular and cellular assays to evaluate pyroptosis, mitochondrial integrity, and mitophagy.

Main Results:

  • Excessive orthodontic traction in rats induced masticatory muscle atrophy with NLRP3 inflammasome activation and increased myocyte pyroptosis.
  • Atrophied muscles showed reduced mitochondrial numbers, overactivated mitophagy, and impaired mitochondrial function.
  • Inhibition of NLRP3 suppressed pyroptosis, alleviated muscle atrophy, improved mitochondrial dysfunction, and reduced excessive mitophagy.
  • In vitro studies confirmed that NLRP3 knockdown mitigated pyroptosis, atrophy, mitochondrial damage, and reactive oxygen species production.

Conclusions:

  • NLRP3 inflammasome activation is a key driver of masticatory muscle atrophy.
  • NLRP3 induces pyroptosis, mitochondrial dysfunction, and mitophagy, contributing to muscle mass loss.
  • Targeting the NLRP3 inflammasome presents a potential therapeutic strategy for masticatory muscle atrophy.